Furthermore, a similar correlation of S100A9 with shorter survival was also detected in two independent cohorts of glioblastoma (Supplementary Fig. 5g,h and Supplementary Table 19), a primary brain tumor including focal brain radiotherapy as part of the standard of care61. Here, S100A9 is linked to glioblastoma.